US › Healthcare

Vaxcyte Inc (PCVX)

US · Healthcare · Biotechnology

$54.69+2.17%
Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue
$0
Net profit
$-320.6M
Profit YoY
-127.8%
EPS
$-2.30
EPS estimate
$-1.77

EPS came in at -2.30 against a street estimate of -1.77 — a miss of 29.9%.

Key statistics

Market cap
$7.81B
Forward P/E
0.0
P/B
2.61
Book value
$20.76
EPS (TTM)
$-6.89
52-week high
$65.00
52-week low
$29.08
50-day MA
$52.94
200-day MA
$52.06
Beta
1.22

Analyst view

Analysts rate Vaxcyte Inc a strong buy (10 buy, 0 hold, 0 sell out of 10) with an average price target of $109.00.

Shareholding

Insiders
0.50%
Institutions
113.44%

Largest institutional holders

FundStake
HHG PLC11.48%
FMR Inc11.42%
T. Rowe Price Investment Management,Inc.8.40%
RA Capital Management, LLC7.95%
BlackRock Inc7.60%
Vanguard Portfolio Management, LLC4.35%
Vanguard Capital Management, LLC4.34%
Wellington Management Company LLP3.89%

Recent filings & reports

DocumentDate
Board / officer change · Q3 20262026-07-15
Board / officer change · Q2 20262026-06-23
Shareholder vote results · Q2 20262026-06-16
Quarterly report · Q1 20262026-05-06
Results announced · Q2 20262026-05-06
Proxy statement · Q2 20262026-04-23
Annual report FY20252026-02-24
Quarterly report · Q3 20252025-11-04

Readable in the app.

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Vaxcyte Inc — free to start.

Google PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncUnitedHealth Group IncorporatedMerck & Company IncNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncNovo Nordisk A/SAmgen IncAbbott LaboratoriesGilead Sciences Inc

Data updated 2026-08-05.